Impact of MRD on the outcome of patients with AML in the context of ELN2017 risk classification. CIR and OS of patients who were MRD⁻ categorized according to the ELN2017 classification compared with BAALC MRD⁺ (A-B) and MN1 MRD⁺ (C-D) patients or those with NPM1-mutated MRD (E-F).